Apollo Healthtech, the demerged omni-channel pharmacy and digital health arm of Apollo Hospitals, is preparing for a stock market listing by the January-March quarter of 2027. Krishnan Akhileswaran, Group Chief Financial Officer, said, “It’s just a value unlock for the shareholders. The promoters of Apollo will also be promoters of the new company and they will also be directors in the new company. So, there is no change from that standpoint.” The application has already been filed with stock exchanges, and further approvals from the Competition Commission of India (CCI) and the National Company Law Tribunal (NCLT) will follow. Apollo Hospitals reported a 42% year-on-year rise in consolidated net profit to about $50 million in the first quarter, driven by strong growth across its business segments, with revenue rising 15% to approximately $700 million.
For entrepreneurs, the demerger and planned listing highlight new opportunities in India’s healthcare sector, particularly in technology-led services and digital health solutions. Chairman Dr. Prathap C Reddy said, “The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and omnichannel healthcare ecosystem.” Alongside the restructuring, Apollo plans to add over 4,300 beds in five years with an investment of about $910 million, focusing on metros and major cities.
